Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes

[1]  K. Kario,et al.  Effects of luseogliflozin on arterial properties in patients with type 2 diabetes mellitus: The multicenter, exploratory LUSCAR study , 2020, Journal of clinical hypertension.

[2]  J. Pankow,et al.  Association of insulin resistance, from mid-life to late-life, with aortic stiffness in late-life: the Atherosclerosis Risk in Communities Study , 2020, Cardiovascular Diabetology.

[3]  Yu Xu,et al.  Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non‐invasive score , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[4]  Soon-Hee Lee,et al.  Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the REBOUND study , 2019, Cardiovascular Diabetology.

[5]  T. Berendschot,et al.  The oral glucose tolerance test-derived incremental glucose peak is associated with greater arterial stiffness and maladaptive arterial remodeling: The Maastricht Study , 2019, Cardiovascular Diabetology.

[6]  W. Rathmann,et al.  Glucose and insulin levels are associated with arterial stiffness and concentric remodeling of the heart , 2019, Cardiovascular diabetology.

[7]  I. Shimomura,et al.  Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes , 2019, Diabetes Therapy.

[8]  A. Nakashima,et al.  Effects of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin on Blood Pressure in Hypertensive Patients with Type 2 Diabetes Mellitus. , 2019, American journal of hypertension.

[9]  F. Doyle,et al.  Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range , 2019, Diabetes Care.

[10]  M. Montaudon,et al.  Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome , 2019, Diabetes Care.

[11]  A. Kroon,et al.  Metformin use in type 2 diabetic patients is not associated with lower arterial stiffness: the Maastricht Study , 2019, Journal of hypertension.

[12]  L. Tarnow,et al.  Arterial stiffness in people with Type 2 diabetes and obstructive sleep apnoea , 2018, Diabetic medicine : a journal of the British Diabetic Association.

[13]  Andrea Facchinetti,et al.  Head-to-head comparison of the accuracy of Abbott FreeStyle Libre and Dexcom G5 mobile. , 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[14]  K. Kario,et al.  Proposed Cutoff Value of Brachial-Ankle Pulse Wave Velocity for the Management of Hypertension. , 2017, Circulation journal : official journal of the Japanese Circulation Society.

[15]  Y. Someya,et al.  Relationships Among Conventional Cardiovascular Risk Factors and Lifestyle Habits With Arterial Stiffness in Type 2 Diabetic Patients , 2017, Journal of clinical medicine research.

[16]  I. Shimomura,et al.  Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus , 2017, Scientific Reports.

[17]  G. Salles,et al.  Correlates of Aortic Stiffness Progression in Patients With Type 2 Diabetes: Importance of Glycemic Control , 2015, Diabetes Care.

[18]  H. Watada,et al.  Morningness–eveningness questionnaire score and metabolic parameters in patients with type 2 diabetes mellitus , 2014, Chronobiology international.

[19]  R. Takayanagi,et al.  Brachial-Ankle Pulse Wave Velocity Predicts All-Cause Mortality and Cardiovascular Events in Patients With Diabetes: The Kyushu Prevention Study of Atherosclerosis , 2014, Diabetes Care.

[20]  Masanori Munakata,et al.  Brachial-ankle pulse wave velocity in the measurement of arterial stiffness: recent evidence and clinical applications. , 2014, Current hypertension reviews.

[21]  Zhao Li,et al.  Impact of Admission Glycemic Variability, Glucose, and Glycosylated Hemoglobin on Major Adverse Cardiac Events After Acute Myocardial Infarction , 2013, Diabetes Care.

[22]  Y. Bao,et al.  Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients , 2013, Cardiovascular Diabetology.

[23]  Yosuke Okada,et al.  Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus , 2013, Cardiovascular Diabetology.

[24]  J. Filipovský,et al.  Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. , 2012, Journal of hypertension.

[25]  Pratik Choudhary,et al.  Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. , 2011, Diabetes technology & therapeutics.

[26]  Z. Li,et al.  Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes , 2011, Cardiovascular Diabetology.

[27]  R. Casamitjana,et al.  Repeated Episodes of Hypoglycemia as a Potential Aggravating Factor for Preclinical Atherosclerosis in Subjects With Type 1 Diabetes , 2010, Diabetes Care.

[28]  A. Ertl,et al.  Effects of Acute Hypoglycemia on Inflammatory and Pro-atherothrombotic Biomarkers in Individuals With Type 1 Diabetes and Healthy Individuals , 2010, Diabetes Care.

[29]  D. Newby,et al.  Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation , 2010, Diabetes Care.

[30]  K. Khunti,et al.  Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity , 2010, Diabetologia.

[31]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  T. Tsunoda,et al.  Long-term pioglitazone therapy improves arterial stiffness in patients with type 2 diabetes mellitus. , 2009, Metabolism: clinical and experimental.

[33]  Grant D. Huang,et al.  Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.

[34]  Michael E. Miller,et al.  Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.

[35]  Diederick Grobbee,et al.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.

[36]  T. Yoshikawa,et al.  Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. , 2008, Metabolism: clinical and experimental.

[37]  R. Testa,et al.  Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients , 2008, Diabetes.

[38]  Jean-Paul Cristol,et al.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.

[39]  D. Kass,et al.  Mechanisms, pathophysiology, and therapy of arterial stiffness. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[40]  L. De Angelis,et al.  Sex Differences in Age-Related Stiffening of the Aorta in Subjects With Type 2 Diabetes , 2004, Hypertension.

[41]  A. Yamashina,et al.  Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[42]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[43]  T. Shoji,et al.  Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. , 1999, Diabetes care.

[44]  The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial , 1995, Diabetes.

[45]  W. F. Taylor,et al.  Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability , 1970, Diabetes.

[46]  P. Gómez-Fernández,et al.  Effect of dapagliflozin on arterial stiffness in patients with type 2 diabetes mellitus. , 2019 .

[47]  M. Özkaya,et al.  Action to Control Cardiovascular Risk in Diabetes , 2013 .

[48]  S. Schinner.  Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .

[49]  S. Schinner.  Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2009 .

[50]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[51]  Daniel J Cox,et al.  Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. , 2003, Diabetes technology & therapeutics.